Improvement in neuroleptic-induced akathisia with intravenous iron treatment in a patient with iron deficiency [5]

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 78, Issue 5, 2007, Pages 548-

  Cotter, Paul E ^a   O'Keeffe, Shaun T ^a,b  

^a UNIVERSITY HOSPITAL GALWAY   (Ireland)

^b Merlin Park University Hospital   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ALPRAZOLAM; BENZATROPINE; FERRITIN; FERROUS GLUCONATE; FERROUS SUCROSE; IRON; IRON DERIVATIVE; PROPRANOLOL; RISPERIDONE; THIORIDAZINE; UNCLASSIFIED DRUG; NEUROLEPTIC AGENT;

AGED; AKATHISIA; ANAMNESIS; CASE REPORT; DRUG DOSE REDUCTION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; EPIGASTRIC DISCOMFORT; FERRITIN BLOOD LEVEL; HUMAN; IRON DEFICIENCY; LABORATORY TEST; LETTER; MALE; NAUSEA; NEUROLOGIC EXAMINATION; PRIORITY JOURNAL; RATING SCALE; SCHIZOPHRENIA; SCREENING TEST; UNSPECIFIED SIDE EFFECT; INTRAVENOUS DRUG ADMINISTRATION; TREATMENT OUTCOME;

AGED; AKATHISIA, DRUG-INDUCED; ANTIPSYCHOTIC AGENTS; HUMANS; INFUSIONS, INTRAVENOUS; IRON; MALE; RISPERIDONE; SCHIZOPHRENIA; TREATMENT OUTCOME;

EID: 34247180689     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp.2006.101014     Document Type: Letter

References (5)

1. Brown KW, Glen SE, White T. Low serum iron status and akathisia. Lancet 1987;1:1234-6.
2. Barnes TR, Halstead SM, Little PW. Relationship between iron statvs and chronic akathisia in an inpatient population with chronic schizophrenia. Br J Psychiatry 1992;161:791-6.
3. Kuloglu M, Atmaca M, Ustundag B, et al. Serum iron levels in schizophrenic patients with or without akathisia. Eur Neuropsychopharmacol 2003;13:67-71.
4. Guyatt GH, Oxman AD, Ali M, et al. Laboratory diagnosis of iron-deficiency anemia: an overview. J Gen Intern Med 1992;7:145-53.
5. O'Keeffe S, Gavin K, Lavan J. Iron status and restless legs syndrome in the elderly. Age Ageing 1994;23:200-3.